glp-1 agonist drugs oral Could a once-a-day pill replace weight loss injections? Phase II drug trial shows promising results List of GLP-1 Receptor Agonists

Ngondi JL, Oben JE, Minka SR

In clinical trials, semaglutide at the 2.4mg weekly dose (Wegovy) produced average weight loss of approximately 15 percent of body weight

*Product Packaging may vary

M.LekvenA

JS is a 30-year-old right-handed male with a longstanding history of medically refractory epilepsy, initially diagnosed at age 14, and a more recent history of sTBI sustained after being struck by a motor vehicle while riding a scooter His epilepsy history includes generalized tonic-clonic seizures (GTCs), with the first documented seizure occurring in 2008, involving convulsive activity, drooling, unresponsiveness, and postictal confusion